Cargando…
Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015–2022): A Retrospective Study
BACKGROUND: The Zero Mother Mortality Preeclampsia (ZOOM) program was adopted as an accelerated initiative to curb mortality related to hypertensive disorders in pregnancy, including preeclampsia. This single-center, retrospective study in Bandung, West Java, aims to evaluate the impact of the ZOOM...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373510/ https://www.ncbi.nlm.nih.gov/pubmed/37481698 http://dx.doi.org/10.12659/MSM.941097 |
_version_ | 1785078583957389312 |
---|---|
author | Pribadi, Adhi Hidayat, Dini Sasotya, R.M. Sonny Aziz, Muhammad Alamsyah Nurdiawan, Windi Pramatirta, Akhmad Yogi Siddiq, Amillia Mose, Johanes Cornelius Hidayat, Yudi Mulyana Nugrahani, Annisa Dewi Santoso, Dhanny Primantara Johari Permadi, Wiryawan |
author_facet | Pribadi, Adhi Hidayat, Dini Sasotya, R.M. Sonny Aziz, Muhammad Alamsyah Nurdiawan, Windi Pramatirta, Akhmad Yogi Siddiq, Amillia Mose, Johanes Cornelius Hidayat, Yudi Mulyana Nugrahani, Annisa Dewi Santoso, Dhanny Primantara Johari Permadi, Wiryawan |
author_sort | Pribadi, Adhi |
collection | PubMed |
description | BACKGROUND: The Zero Mother Mortality Preeclampsia (ZOOM) program was adopted as an accelerated initiative to curb mortality related to hypertensive disorders in pregnancy, including preeclampsia. This single-center, retrospective study in Bandung, West Java, aims to evaluate the impact of the ZOOM program implemented from 2015 to 2022. MATERIAL/METHODS: We analyzed 19,176 childbirths and associated maternal deaths due to hypertension in pregnancy. Diagnoses were validated using blood pressure measures, lab tests including urine protein, liver function, blood profiles, platelets, X-ray, echocardiography, and COVID-19 testing. The case fatality rate (CFR) was assessed to evaluate the impact of the ZOOM program. RESULTS: Hypertension in pregnancy was identified in 25.1% of cases, with 9.8% and 1.4% attributed to preeclampsia and eclampsia, respectively. Maternal deaths associated with hypertension accounted for 36.6%, with the majority linked to eclampsia. Heart failure (45.5%) and Hemolysis, Elevated Liver enzymes, and Low Platelets (HELLP) syndrome (22%) were the most common complications. The CFR decreased from 61% in 2018 to 10% in 2022. The overall CFR from 2015 to 2022 was 1.3%, with the highest fatality rate observed in eclampsia cases (9.4%). However, a declining trend was seen since 2018, reaching a low of 0.2% in 2021. CONCLUSIONS: The implementation of the ZOOM program, which includes preeclampsia re-education, early detection, prompt intervention, protocol adjustments, and a refined referral system, led to a marked reduction in maternal deaths from hypertensive pregnancy disorders. |
format | Online Article Text |
id | pubmed-10373510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103735102023-07-28 Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015–2022): A Retrospective Study Pribadi, Adhi Hidayat, Dini Sasotya, R.M. Sonny Aziz, Muhammad Alamsyah Nurdiawan, Windi Pramatirta, Akhmad Yogi Siddiq, Amillia Mose, Johanes Cornelius Hidayat, Yudi Mulyana Nugrahani, Annisa Dewi Santoso, Dhanny Primantara Johari Permadi, Wiryawan Med Sci Monit Clinical Research BACKGROUND: The Zero Mother Mortality Preeclampsia (ZOOM) program was adopted as an accelerated initiative to curb mortality related to hypertensive disorders in pregnancy, including preeclampsia. This single-center, retrospective study in Bandung, West Java, aims to evaluate the impact of the ZOOM program implemented from 2015 to 2022. MATERIAL/METHODS: We analyzed 19,176 childbirths and associated maternal deaths due to hypertension in pregnancy. Diagnoses were validated using blood pressure measures, lab tests including urine protein, liver function, blood profiles, platelets, X-ray, echocardiography, and COVID-19 testing. The case fatality rate (CFR) was assessed to evaluate the impact of the ZOOM program. RESULTS: Hypertension in pregnancy was identified in 25.1% of cases, with 9.8% and 1.4% attributed to preeclampsia and eclampsia, respectively. Maternal deaths associated with hypertension accounted for 36.6%, with the majority linked to eclampsia. Heart failure (45.5%) and Hemolysis, Elevated Liver enzymes, and Low Platelets (HELLP) syndrome (22%) were the most common complications. The CFR decreased from 61% in 2018 to 10% in 2022. The overall CFR from 2015 to 2022 was 1.3%, with the highest fatality rate observed in eclampsia cases (9.4%). However, a declining trend was seen since 2018, reaching a low of 0.2% in 2021. CONCLUSIONS: The implementation of the ZOOM program, which includes preeclampsia re-education, early detection, prompt intervention, protocol adjustments, and a refined referral system, led to a marked reduction in maternal deaths from hypertensive pregnancy disorders. International Scientific Literature, Inc. 2023-07-23 /pmc/articles/PMC10373510/ /pubmed/37481698 http://dx.doi.org/10.12659/MSM.941097 Text en © Med Sci Monit, 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Clinical Research Pribadi, Adhi Hidayat, Dini Sasotya, R.M. Sonny Aziz, Muhammad Alamsyah Nurdiawan, Windi Pramatirta, Akhmad Yogi Siddiq, Amillia Mose, Johanes Cornelius Hidayat, Yudi Mulyana Nugrahani, Annisa Dewi Santoso, Dhanny Primantara Johari Permadi, Wiryawan Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015–2022): A Retrospective Study |
title | Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015–2022): A Retrospective Study |
title_full | Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015–2022): A Retrospective Study |
title_fullStr | Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015–2022): A Retrospective Study |
title_full_unstemmed | Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015–2022): A Retrospective Study |
title_short | Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015–2022): A Retrospective Study |
title_sort | assessing the impact of the zero mother mortality preeclampsia program on maternal mortality rates at a single center in bandung, west java (2015–2022): a retrospective study |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373510/ https://www.ncbi.nlm.nih.gov/pubmed/37481698 http://dx.doi.org/10.12659/MSM.941097 |
work_keys_str_mv | AT pribadiadhi assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT hidayatdini assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT sasotyarmsonny assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT azizmuhammadalamsyah assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT nurdiawanwindi assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT pramatirtaakhmadyogi assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT siddiqamillia assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT mosejohanescornelius assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT hidayatyudimulyana assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT nugrahaniannisadewi assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT santosodhannyprimantarajohari assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy AT permadiwiryawan assessingtheimpactofthezeromothermortalitypreeclampsiaprogramonmaternalmortalityratesatasinglecenterinbandungwestjava20152022aretrospectivestudy |